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Kurtzman  et  al5 reported  promising  results  in 3  patients
with  recalcitrant  cutaneous  DM  who  were  treated  with  TOF.
Subsequently,  Paik  and Christopher-Stine4 reported  a good
response  to  TOF treatment  in  an adult  DM  patient  who
had  failed  to  respond  to  multiple  therapies.  In  a  review
by  Cinats  et  al6 of  emerging  uses  of  JAK  inhibitors  in skin
diseases,  including  psoriasis,  atopic dermatitis,  alopecia
areata,  vitiligo,  DM, and  graft  versus  host  disease,  adverse
effects  reported  included  infections  in TOF-treated  patients
and  anemia  and  thrombocytopenia  in those  treated  with
ruxolitinib.6
In  the  last  year,  clinical  cases  have been  published
demonstrating  a  therapeutic  effect  of  TOF  not  only in skin
manifestations,  but  also  interstitial  lung disease  and  severe
refractory  calcinosis,  with  no  notable  side  effects1,3,7--9
except  for  transient  hypercalcemia  and increased  body mass
index  in  2 patients.1
The  present  case  is  the  sixth  published  description  of
amyopathic  DM  treated  with  TOF.  As  in  the  5 previously  pub-
lished  cases,3,5,7 the patient  improved  rapidly  and treatment
was  well  tolerated.
Clinical  trials  are  required  to  reliably  confirm  the efficacy
and  safety  profile  of  this  treatment.  A clinical  trial  is  cur-
rently  underway  to  evaluate  the  efficacy  of  TOF  treatment
of treatment-refractory  DM.10
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Adult-Onset Eccrine Angiomatous
Hamartoma: A Case Report With
Ultrasound  Findings
Hamartoma angiomatoso ecrino en  la  edad
adulta y sus  hallazgos ecográficos
To  the  Editor:
Eccrine  angiomatous  hamartoma  (EAH)  is  a  rare,  benign
cutaneous  tumor  composed  of  vascular  and  eccrine  ele-
 Please cite this article as: Vilas-Sueiro A, López-Armesto A,
Mosquera-Martínez MT, Monteagudo B. Hamartoma angiomatoso
ecrino en la edad adulta y sus hallazgos ecográficos. Actas Dermosi-
filiogr. 2021;112:376--378.
ments.  It  is  most commonly  diagnosed  during  the first  years
of  life,  although  there  are  reports  of cases  diagnosed  in
adults.  We  report  the ultrasound  findings  of  a 46-year-old
patient  with  a left plantar  lesion,  histopathological  diagnosis
of  which confirmed  suspicion  of EAH.
Case  Description
A 46-year-old  woman  was  seen  for  mild  discomfort  in the
sole  of  her  left foot when  walking.  During  the  anam-
nesis,  she  reported  a  lesion  in the midfoot,  specifically
the  plantar  support  area, that  had  appeared  approxi-
mately  10  years  earlier.  Clinical  examination  revealed  a
bluish,  rubbery,  compressible  nodule  of  approximately  3  cm
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Figure  1  Clinical  image  showing  a  bluish  nodular  lesion  of
approximately  3 cm  in  size.
(Fig.  1). Skin  ultrasound  with  a  high-frequency  (6--19 MHz)
linear  probe  (Esaote  MySix®) revealed  a  poorly  defined
dermal--hypodermal  lesion.  Ultrasound  in B  mode showed
tubular  hypoechoic  foci  with  mild  posterior  acoustic  rein-
forcement  and  isolated  hyperechoic  structures  (Fig.  2A).
Color  Doppler  mode  revealed  a moderate  increase  in  intrale-
sional  uptake  that corresponded  to  high  flow  and  low
resistance  in  spectral  mode  (Fig.  2B).  Histology  showed  pro-
liferation  of  dilated  vessels  with  disorganized  distribution  at
the  level  of  the  middle  and deep  dermis,  as  well  as  eccrine
gland  proliferation  and  foci  of  adipose  tissue (Fig.  3). Due
to  the  size  of the lesion  and  the possible  consequences  of
excisional  surgery,  it was  decided,  in  agreement  with  the
patient,  not  to  remove  the lesion  and  to  adopt  a wait-and-
see approach.
Discussion
EAH is  a sometimes  congenital  skin  tumor  that  generally
presents  during  the  first  years  of  life. However,  adult  onset,
as  in  the  present  case,  has  been described.1
The  etiology  and pathogenesis  of EAH are poorly  under-
stood.  It  has  been  proposed  that  EAH is  a consequence  of
failed  interaction  between  the  epithelial  and  mesenchymal
components  that  leads  to  abnormal  proliferation  of  vas-
cular  and  adnexal  structures.  It  has  also  been  postulated
that  onset  in  adulthood  may  be a  consequence  of repeated
microtrauma.2 Appearance  of  EAH  in adulthood  may  also  be
due  to  an  absence  of symptoms  during  the  first  few  years
and  a consequent  delay  in diagnosis.
EAH  usually  manifests  as  a  single  brownish,  blue,  or  red-
dish  lesion.  Multiple  lesions  can  develop,  usually  in the
distal  areas  of  the  extremities,  palms,  and  soles.3 Most  cases
are  asymptomatic,  although  some  patients  may  experience
hyperhidrosis  and  local  pain  caused  by  neural  infiltration  of
the  eccrine  component.4
In  addition  to  the  findings  of  the clinical  examination,
some  recently  described  dermoscopic  findings  may  be  diag-
nostically  useful.5 We decided  to  perform  skin  ultrasound
because  it  is  a  rapid, noninvasive  technique  that allows
visualization  of the  deep component  of  lesions,  and  identi-
fication  of vascular  lesions  using  color  Doppler  mode.  In our
patient,  ultrasound  revealed  a poorly  delimited  structure
at  the dermal--hypodermal  level with  poorly  defined  hypoe-
choic  areas,  which may  correspond  to  intralesional  vascular
areas.  Furthermore,  we  observed  small  hyperechoic  areas
that  may  correspond  to  adipose  tissue  septa  interspersed
throughout  the lesion.
Diagnosis  of  EAH  is  clinical,  although  histopathologic
confirmation  is  necessary.  We  observed  proliferation  of
eccrine  glands,  unstructured  angiomatous  capillaries  at the
level  of  the  dermis,  and variable  amounts  of  adipose  tissue.6
The  differential  diagnosis  of  EAH  includes  the  following:  vas-
cular  malformations;  tufted  angioma  (develops  during  the
first  5 years  of  life  and  can be associated  with  hypertri-
chosis  or  hyperhidrosis);  smooth  muscle hamartoma  (solitary
plaques  of childhood  onset  accompanied  by  hypertrichosis
and  hyperpigmentation);  and  rubber  bleb  nevus  (blue,  nodu-
lar,  depressed  lesions).7 However,  eccrine  nevus  is  the entity
most  difficult  to  differentiate  from  EAH.  Unlike  EAH,  which
is  a mixed  variant,  eccrine  nevus  consists  exclusively  of
eccrine  tissue.  Furthermore,  while  associated  hyperhidro-
sis  occurs  in almost  all  cases of  eccrine  nevus,  this  clinical
finding  is  observed  in  only  one  third of  EAH  cases.8
Definitive  treatment  consists  of  surgical  resection,
although  given  the  benign  nature  of  the tumor  resection  is
not  always  necessary,  and  is  usually  only considered  in cases
involving  bothersome  symptoms  such as  hyperhidrosis.  Other
therapeutic  alternatives  (eg  intralesional  sclerosing  agents,
botulinum  toxin,  or  laser)  may  be  useful  in  certain  patients.9
The  case  presented  here  underscores  the value  of  imag-
ing  the differential  diagnosis  of EAH.
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Figure  2  A,  B-mode  ultrasound  image  showing  a  poorly  delimited,  largely  hypoechoic  lesion  containing  tubular  hypoechoic  struc-
tures and  scattered  hyperechoic  areas.  B,  Spectral  Doppler  ultrasound  image,  showing  focal  intralesional  hypervascularization
corresponding  to  high-flow,  low-resistance  vessels.
Figure  3  Histopathology  image  (hematoxylin-eosin,  original
magnification  ×10)  showing  proliferation  of  eccrine  structures
in the  deep  dermis,  dilated  capillaries,  and foci  of  adipose  tis-
sue.
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